Inad Janineh, DO
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.3%), food and beverage and education — rather than concentrated in one kind of arrangement. TELA Bio, Inc. accounts for 75.1% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $1,153 and has fallen 92.3% since, to $88 in 2025. That places this record below the midpoint for surgery clinicians in MI, where the typical reported total is $1,459.
Across 28 payments — averaging $64.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$1K
- AbbVie$205
- Abbott$97
- Smith+Nephew$57
- Acera Surgical, Inc.$30
- Solventum Corporation$26
- plus $36 from 2 others
What the payments were for
- Consulting fees$1,00055%
- Food & beverage$78944%
- Education$201%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 9 | $1,358 |
| AbbVie(2 entities) | 11 | $205 |
| Abbott | 1 | $97 |
| Smith+Nephew | 3 | $57 |
| Acera Surgical, Inc. | 1 | $30 |
| Solventum Corporation | 1 | $26 |
| CSL Behring | 1 | $20 |
| Integra Lifesciences Corporation | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,809 in reported general payments places this provider in the 50th percentile of 1,081 surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 57 | $512 |
| Cephalexin | 101 | $396 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 81 | $147 |
| Mupirocin | 14 | $70 |
| Methylprednisolone | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other surgery in Troy
- David ChengelisTroy$57K
- Robert BartlettAnn Arbor$859K
- Matthew FourmanMonroe$492K
- Bruce McIntoshRochester Hills$435K
- Jon SchramZeeland$261K
- Eric DaviesBrighton$258K
- Robert LyonsYpsilanti$196K
- Joel StrehlTraverse City$170K
- John LimClinton Township$141K
- Bellal JosephDetroit$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.